128 related articles for article (PubMed ID: 21482774)
1. Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen.
Mendes-Pereira AM; Sims D; Dexter T; Fenwick K; Assiotis I; Kozarewa I; Mitsopoulos C; Hakas J; Zvelebil M; Lord CJ; Ashworth A
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2730-5. PubMed ID: 21482774
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of Ras GTPase‑activating protein 1 is associated with poor survival of breast invasive ductal carcinoma patients.
Liu Y; Liu T; Sun Q; Niu M; Jiang Y; Pang D
Oncol Rep; 2015 Jan; 33(1):119-24. PubMed ID: 25394563
[TBL] [Abstract][Full Text] [Related]
3. Activating
Toy W; Weir H; Razavi P; Lawson M; Goeppert AU; Mazzola AM; Smith A; Wilson J; Morrow C; Wong WL; De Stanchina E; Carlson KE; Martin TS; Uddin S; Li Z; Fanning S; Katzenellenbogen JA; Greene G; Baselga J; Chandarlapaty S
Cancer Discov; 2017 Mar; 7(3):277-287. PubMed ID: 27986707
[TBL] [Abstract][Full Text] [Related]
4. Constructing a novel prognostic model for triple-negative breast cancer based on genes associated with vasculogenic mimicry.
Ren Y; Feng L; Tan Z; Zhou F; Liu S
Aging (Albany NY); 2024 May; 16(9):8086-8109. PubMed ID: 38728245
[TBL] [Abstract][Full Text] [Related]
5. Tafazzin mediates tamoxifen resistance by regulating cellular phospholipid composition in ER-positive breast cancer.
Li X; Zhang Y; Zhang T; Zhao L; Lin CG; Hu H; Zheng H
Cancer Gene Ther; 2024 Jan; 31(1):69-81. PubMed ID: 37935981
[TBL] [Abstract][Full Text] [Related]
6. Selective Concurrence of the Long Non-Coding RNA MALAT1 and the Polycomb Repressive Complex 2 to Promoter Regions of Active Genes in MCF7 Breast Cancer Cells.
Arratia F; Fierro C; Blanco A; Fuentes S; Nahuelquen D; Montecino M; Rojas A; Aguilar R
Curr Issues Mol Biol; 2023 May; 45(6):4735-4748. PubMed ID: 37367050
[TBL] [Abstract][Full Text] [Related]
7. Transfection of Sponge Cells and Intracellular Localization of Cancer-Related MYC, RRAS2, and DRG1 Proteins.
Dominko K; Talajić A; Radić M; Vidaček NŠ; Vlahoviček K; Bosnar MH; Ćetković H
Mar Drugs; 2023 Feb; 21(2):. PubMed ID: 36827160
[TBL] [Abstract][Full Text] [Related]
8. K-RAS Associated Gene-Mutation-Based Algorithm for Prediction of Treatment Response of Patients with Subtypes of Breast Cancer and Especially Triple-Negative Cancer.
Johnson H; Ali A; Zhang X; Wang T; Simoulis A; Wingren AG; Persson JL
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358741
[TBL] [Abstract][Full Text] [Related]
9. Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?
Krossa I; Strub T; Aplin AE; Ballotti R; Bertolotto C
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230787
[TBL] [Abstract][Full Text] [Related]
10. RAD21 Confers Poor Prognosis and Affects Ovarian Cancer Sensitivity to Poly(ADP-Ribose)Polymerase Inhibitors Through DNA Damage Repair.
Gou R; Li X; Dong H; Hu Y; Liu O; Liu J; Lin B
Front Oncol; 2022; 12():936550. PubMed ID: 35860572
[TBL] [Abstract][Full Text] [Related]
11. Molecular vulnerabilities and therapeutic resistance in hormone receptor positive and HER2 dependent breast cancer tumours.
Velaga R; Tanaka S; Toi M
Cancer Drug Resist; 2022; 5(2):487-497. PubMed ID: 35800379
[TBL] [Abstract][Full Text] [Related]
12. Development of a dynamic network biomarkers method and its application for detecting the tipping point of prior disease development.
Han C; Zhong J; Zhang Q; Hu J; Liu R; Liu H; Mo Z; Chen P; Ling F
Comput Struct Biotechnol J; 2022; 20():1189-1197. PubMed ID: 35317238
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of vps54 aggravates tamoxifen-induced cytotoxicity in fission yeast.
Lee S; Nam M; Lee AR; Baek ST; Kim MJ; Kim JS; Kong AH; Lee M; Lee SJ; Kim SY; Kim DU; Hoe KL
Genomics Inform; 2021 Dec; 19(4):e39. PubMed ID: 35172472
[TBL] [Abstract][Full Text] [Related]
14. Genomics-guided pre-clinical development of cancer therapies.
Francies HE; McDermott U; Garnett MJ
Nat Cancer; 2020 May; 1(5):482-492. PubMed ID: 35121986
[TBL] [Abstract][Full Text] [Related]
15. Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.
Ring A; Campo D; Porras TB; Kaur P; Forte VA; Tripathy D; Lu J; Kang I; Press MF; Jeong YJ; Snow A; Zhu Y; Zada G; Wagle N; Lang JE
Ann Surg Oncol; 2022 May; 29(5):2882-2894. PubMed ID: 35000083
[TBL] [Abstract][Full Text] [Related]
16. Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance.
Tak E; Kim M; Cho Y; Choi S; Kim J; Han B; Kim HD; Jang CS; Kim JE; Hong YS; Kim SY; Kim TW
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34779495
[TBL] [Abstract][Full Text] [Related]
17. NSD1: A Lysine Methyltransferase between Developmental Disorders and Cancer.
Tauchmann S; Schwaller J
Life (Basel); 2021 Aug; 11(9):. PubMed ID: 34575025
[TBL] [Abstract][Full Text] [Related]
18. Nipped-B-like Protein Sensitizes Esophageal Squamous Cell Carcinoma Cells to Cisplatin via Upregulation of PUMA.
Zhang S; Zhou Y; Wang Q; Donahue K; Feng J; Yao Y; Chen A; Li X; Hong L
Technol Cancer Res Treat; 2020; 19():1533033820960726. PubMed ID: 33034274
[TBL] [Abstract][Full Text] [Related]
19. Single-Sample Node Entropy for Molecular Transition in Pre-deterioration Stage of Cancer.
Han C; Zhong J; Hu J; Liu H; Liu R; Ling F
Front Bioeng Biotechnol; 2020; 8():809. PubMed ID: 32766227
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Role of
Hwang KT; Kim BH; Oh S; Park SY; Jung J; Kim J; Choi IS; Jeon SY; Kim WY
J Breast Cancer; 2019 Dec; 22(4):548-561. PubMed ID: 31897329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
